
Bibliothèques de composés
Les bibliothèques de composés sont des collections de composés stockés qui sont largement utilisées pour identifier efficacement des molécules d'intérêt. Ces bibliothèques sont des outils essentiels en recherche et développement, notamment dans la recherche de nouveaux médicaments, car elles permettent de réaliser des criblages et des contrôles de qualité approfondis de manière efficace. Les bibliothèques de composés sont utiles pour effectuer des analyses très exigeantes, réduisant considérablement le coût et le temps associés à ces processus. Chez CymitQuimica, nous proposons une vaste gamme de bibliothèques de composés de haute qualité, conçues pour répondre aux besoins de recherche et développement dans divers domaines scientifiques et industriels. Notre catalogue comprend des bibliothèques avec une grande variété de composés, facilitant l'identification et le développement de molécules ayant un potentiel thérapeutique et d'autres applications innovantes.
268 produits trouvés pour "Bibliothèques de composés"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ginsenoside Rg1
CAS :Ginsenoside Rg1 is the main pharmacologically active compound of ginsenosides and has demonstrated pharmacological effects in the cardiovascular system, central nervous system and immune system; Rg1 has protective effect against Aβ25-35-induced toxicity in PC12 cells,might be through the insulin-like growth factor-I receptor (IGF-IR) and estrogen receptor (ER)signaling pathways.Formule :C42H72O14Degré de pureté :95%~99%Couleur et forme :White powderMasse moléculaire :801.024Ginsenoside Re
CAS :Ginsenoside Re, a main phytosterol of Panax ginseng, inhibits Ca(2+) accumulation in mitochondria during cardiac ischemia/reperfusion, which is attributable to nitric oxide (NO)-induced Ca(2+) channel inhibition and K(+) channel activation in cardiac myocytes, acts as a specific agonist for the nongenomic pathway of sex steroid receptors, and NO released from activated eNOS underlies cardiac K(+) channel activation and protection against ischemia-reperfusion injury, G-Re also exerts antiischemic effect and induces angiogenic regeneration.[1,2]Formule :C48H82O18Degré de pureté :95%~99%Couleur et forme :White powderMasse moléculaire :947.16620(R)-Ginsenoside Rg2
CAS :Formule :C42H72O13Degré de pureté :95%~99%Couleur et forme :PowderMasse moléculaire :785.025Ginsenoside Rg2
CAS :Ginsenoside Rg2 suppresses the hepatic glucose production via AMPK-induced phosphorylation of GSK3β and induction of SHP gene expression, suggests that it has therapeutic potential for type 2 diabetic patients.Formule :C42H72O13Degré de pureté :95%~99%Couleur et forme :White powderMasse moléculaire :785.025Ginsenoside Rk3
CAS :Formule :C36H60O8Degré de pureté :95%~99%Couleur et forme :PowderMasse moléculaire :620.868Ginsenoside Rh2
CAS :Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation; ginsenoside Rh2 can suppress RANKL-induced osteoclast differentiation in vitro and in vivo through the regulation of c-Fos and NFATc1 expressions, not excluding the involvement of NF-κB and ERK, it is also suggested to be developed as a therapeutic drug for prevention and treatment of osteoporosis.Formule :C36H62O8Degré de pureté :95%~99%Couleur et forme :White powderMasse moléculaire :622.88420(R)-Ginsenoside Rh2
CAS :Ginsenoside Rh2 is one of the most active components of red ginseng, controlling cancer and other metabolic diseases including osteoclast differentiation; ginsenoside Rh2 can suppress RANKL-induced osteoclast differentiation in vitro and in vivo through the regulation of c-Fos and NFATc1 expressions, not excluding the involvement of NF-κB and ERK, it is also suggested to be developed as a therapeutic drug for prevention and treatment of osteoporosis.Formule :C36H62O8Degré de pureté :20%, 95%, 98%Masse moléculaire :622.873Ginsenoside Rg4
CAS :Formule :C42H70O12Degré de pureté :95%~99%Couleur et forme :PowderMasse moléculaire :767.01(20S)-Protopanaxatriol
CAS :Formule :C30H52O4Degré de pureté :30%, 90%, 95%, 99%Masse moléculaire :476.731Ginsenoside Rf
CAS :GinsenosideRf, as an effective natural product, induces G2/Mphase cell cycle arrest and apoptosis in human osteosarcoma MG-63 cells through the mitochondrial pathway, suggests that it may have a therapeutic effect on human osteosarcoma.Formule :C42H72O14Degré de pureté :95%~99%Couleur et forme :White powderMasse moléculaire :801.024Panasenoside
CAS :Formule :C27H30O16Degré de pureté :95%~99%Couleur et forme :PowderMasse moléculaire :610.521N,N'-dimethyldauricine iodide
Formule :C38H46I2N2O4Degré de pureté :95%~99%Masse moléculaire :848.605Approved Drug Library
<p>A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);</p>Couleur et forme :Odour SolidGolden Scaffold Library
<p>Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source;</p>Couleur et forme :Odour Solid


